Gene · 1131
Papers4,237
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,237
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Calycosin ameliorates osteoarthritis by regulating the imbalance between chondrocyte synthesis and catabolism. | BMC Complement Med Ther | 2024 | 38254101 | PubTator, text mining | PubMed |
| Evaluation of chlorophyll-loaded mesoporous silica nanoparticles for photodynamic therapy on cancer cell lines. | Lasers Med Sci | 2024 | 38253944 | PubTator, text mining | PubMed |
| Wound healing and photoprotection properties of Acanthus ebracteatus Vahl. extracts standardized in verbascoside. | Sci Rep | 2024 | 38253627 | PubTator, text mining | PubMed |
| Insights into estrogen impact in oral health & microbiome in COVID-19. | BMC Microbiol | 2024 | 38245675 | PubTator, text mining | PubMed |
| A single-domain antibody detects and neutralises toxic Aβ42 oligomers in the Alzheimer's disease CSF. | Alzheimers Res Ther | 2024 | 38238842 | PubTator, text mining | PubMed |
| The association of RBX1 and BAMBI gene expression with oocyte maturation in PCOS women. | BMC Med Genomics | 2024 | 38238750 | PubTator, text mining | PubMed |
| Establishment of tumor microenvironment-preserving organoid model from patients with intracranial meningioma. | Cancer Cell Int | 2024 | 38238738 | PubTator, text mining | PubMed |
| ANKRD2 expression combined with TNFRSF19 expression for evaluating the prognosis of oral squamous cell carcinoma patients. | Heliyon | 2024 | 38234906 | PubTator, text mining | PubMed |
| Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastases. | Cancer Immunol Immunother | 2024 | 38231291 | PubTator, text mining | PubMed |
| Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3). | ACS Med Chem Lett | 2024 | 38229752 | PubTator, text mining | PubMed |
| Omics methods predict the prognosis and treatment efficacy of chronic obstructive pulmonary disease. | Chin Med J (Engl) | 2024 | 38214333 | PubTator, text mining | PubMed |
| Advances in nanobiosensors during the COVID-19 pandemic and future perspectives for the post-COVID era. | Nano Converg | 2024 | 38206526 | PubTator, text mining | PubMed |
| Cocaine regulates antiretroviral therapy CNS access through pregnane-x receptor-mediated drug transporter and metabolizing enzyme modulation at the blood brain barrier. | Fluids Barriers CNS | 2024 | 38200564 | PubTator, text mining | PubMed |
| Tumor-specific migration routes of xenotransplanted human glioblastoma cells in mouse brain. | Sci Rep | 2024 | 38195678 | PubTator, text mining | PubMed |
| Good manufacturing practice production of human corneal limbus-derived stromal stem cells and in vitro quality screening for therapeutic inhibition of corneal scarring. | Stem Cell Res Ther | 2024 | 38185673 | PubTator, text mining | PubMed |
| Prunella vulgaris polysaccharide inhibits herpes simplex virus infection by blocking TLR-mediated NF-κB activation. | Chin Med | 2024 | 38185640 | PubTator, text mining | PubMed |
| Betaine alleviates cognitive impairment induced by homocysteine through attenuating NLRP3-mediated microglial pyroptosis in an m6A-YTHDF2-dependent manner. | Redox Biol | 2024 | 38184996 | PubTator, text mining | PubMed |
| PIEZO1 loss-of-function compound heterozygous mutations in the rare congenital human disorder Prune Belly Syndrome. | Nat Commun | 2024 | 38184690 | PubTator, text mining | PubMed |
| Immunofluorescence study of cytoskeleton in endothelial cells induced with malaria sera. | Malar J | 2024 | 38183117 | PubTator, text mining | PubMed |
| Effects of continuous intravenous infusion with propofol on intestinal metabolites in rats. | Biomed Rep | 2024 | 38169795 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1131/papers?page=9